Online therapy for anxiety in women going through menopause
Official title: Developing an Internet-Delivered Cognitive Behaviour Therapy Program for Women with Perimenopausal Anxiety: a Feasibility and Acceptability Study
Run by Queen's University · NCT06865066 · Data updated 2026-11-12
This study is testing an online therapy program to see if it can help women going through menopause feel less anxious.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 60 Years |
| Sex | Women only |
| Enrollment | 25 (estimated) |
| Sponsor | Queen's University Academic / other |
| Locations | 2 sites (Kingston, Ontario and 1 other locations) |
| Status | Recruiting |
| Started | November 11, 2024 |
| Main results expected | February 28, 2025 |
| Study ends | February 28, 2025 |
| Registry record updated | March 7, 2025 |
| Trial ID | NCT06865066 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are women aged 40-60 who are experiencing perimenopausal anxiety as defined by the STRAW +10 criteria.
✕Probably not a fit
Patients with active psychosis, acute mania, severe substance use disorders, or those who have undergone CBT or hormone therapy in the last six months may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to develop and evaluate an online Cognitive Behavioural Therapy (CBT) and Acceptance Commitment Therapy (ACT) program specifically designed for women experiencing anxiety during perimenopause. Participants will engage in weekly e-CBT sessions tailored to their needs and receive feedback from trained care providers through a secure online platform. The study will assess the program's practicality and effectiveness in reducing anxiety levels through questionnaires administered at various stages of the trial.
Why it matters
Potential benefit: If successful, this program could provide an accessible and effective treatment option for managing anxiety in women during the perimenopausal transition.
How similar studies have gone: Other studies have shown promise in using online psychotherapy for anxiety management, suggesting that this approach could be effective, though this specific application for perimenopausal women is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * In perimenopausal staging (as defined by the STRAW +10 criteria) * Assigned female at birth * Diagnosis of GAD according to DSM-5 by attending psychiatrist on research team * Competence to consent to participate * Ability to speak and read English * Consistent and reliable access to the internet Exclusion Criteria: * Undergone CBT or hormone therapy within the last 6 months will be excluded * Active psychosis * Acute mania * Severe alcohol or substance use disorder * Active suicidal or homicidal ideation
Where it's running
-
Kingston General Hospital
Kingston, Ontario, Canada Recruiting -
Nazanin Alavi
Kingston, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Nazanin Alavi, MD, FRCPC — Queen's University
- Study coordinator: Nazanin Alavi, MD, FRCPC
- Email: nazanin.alavitabari@kingstonhsc.ca
- Phone: 613-544-3310
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Hop extract vs soy isoflavone for menopausal symptoms
This study tests whether a full-spectrum hop extract helps reduce menopausal mood symptoms better than soy isoflavones in peri- and postmenopausal women.
-
Lifestyle changes to ease menopausal symptoms, sleep problems, and anxiety
Researchers are testing whether a structured lifestyle education program helps perimenopausal and postmenopausal women see fewer menopausal symptoms, better sleep, and less anxiety compared to usual care.
-
CARAMEL: Personalizing Heart Risk in Women 40–60
This observational study tests a personalized cardiovascular risk-stratification approach for women aged 40–60 using multi-source data and a digital self-management tool.
-
Samphire Guided Care for Wellbeing at Work
This study tests a 12-week digital program with at-home neuromodulation to see if it helps women with menstrual or perimenopausal symptoms feel better at work and in daily life.
-
Low-level laser acupuncture to improve body shape and composition in overweight menopausal women
This trial will test whether adding low-level multi-acupoint laser acupuncture to WHO-recommended diet and exercise helps overweight or obese menopausal women lose weight and improve body composition.
-
Hemp-derived cannabinoids for menopause and perimenopause symptom relief
This will try hemp-derived cannabinoids versus placebo to see if they reduce physical and psychological symptoms in women aged 40–60 going through perimenopause or menopause.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.